about
A systematic review of the relationship between blood loss and clinical signsMortality of induced abortion, other outpatient surgical procedures and common activities in the United StatesPostpartum haemorrhage: Case definition and guidelines for data collection, analysis, and presentation of immunization safety dataPostpartum hemorrhage prevention in Nepal: a program assessment.Standardizing abortion research outcomes (STAR): a protocol for developing, disseminating and implementing a core outcome set for medical and surgical abortion.A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion.Calibrated delivery drape versus indirect gravimetric technique for the measurement of blood loss after delivery: a randomized trialBringing emergency contraception over the counter: experiences of nonprescription users in France, Norway, Sweden and Portugal.Abortion: what is the problem?Use of medicines changing the face of abortion.Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make?Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countriesContinuing pregnancy after mifepristone and "reversal" of first-trimester medical abortion: a systematic review.Misoprostol for women's health: a review.[First experience of the use of misoprostol as post-abortion care in Libreville, Gabon]How effective are the components of active management of the third stage of labor?Induction of labour in pre-eclamptic women: a randomised trial comparing the Foley balloon catheter with oral misoprostol.Results from a study using misoprostol for management of incomplete abortion in Vietnamese hospitals: implications for task shifting.Where is the "E" in MCH? The need for an evidence-based approach in safe motherhood.Ectopic pregnancy and medical abortion.Infection after medical abortion: a review of the literature.The MamaMiso study of self-administered misoprostol to prevent bleeding after childbirth in rural Uganda: a community-based, placebo-controlled randomised trial.Comment on "Is It Safe to Provide Abortion Pills Over The Counter? A Study on Outcome Following Self-Medication with Abortion Pills".Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia.Neither vaginal nor buccal administration of 800 μg misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot study.Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research.Embracing post-fertilisation methods of family planning: a call to action.Introduction and provision of medical abortion: a tale of two countries in which technology is necessary but not sufficient.Misoprostol for the prevention and treatment of postpartum hemorrhage.First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review.Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam: a randomized controlled trial.Acceptability and feasibility of phone follow-up with a semiquantitative urine pregnancy test after medical abortion in Moldova and Uzbekistan.Results of a pilot study in the U.S. and Vietnam to assess the utility and acceptability of a multi-level pregnancy test (MLPT) for home monitoring of hCG trends after assisted reproduction.Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India (INFORM): a multicentre, open-label, randomised controlled trial.Acceptability and feasibility of 400 μg buccal misoprostol after 200 mg mifepristone for early medical abortion in Georgia.Misoprostol-induced fever and genetic polymorphisms in drug transporters SLCO1B1 and ABCC4 in women of Latin American and European ancestry.Randomized trial assessing home use of two pregnancy tests for determining early medical abortion outcomes at 3, 7 and 14days after mifepristone.Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam.The medical abortion experiences of married and unmarried women in Tunis, Tunisia.A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial.
P50
Q21133652-8C63389C-2663-4A66-86F1-EB7B0D961F16Q21999120-CA2F2E20-76FF-4012-8F80-50DC082DF68BQ31115558-04877D74-E237-4A9B-9EEA-DF5112AF0BFCQ33767725-FB615F21-0AFC-4601-8ABF-191265703B8BQ33808231-3D43C965-CAE9-4611-AE93-1616713ADCDDQ33989746-72D0FAA2-5AE1-4AB7-A3CA-A4D64BA3F272Q34076609-6171B834-5D1B-4EDD-9C08-E56A813DBC73Q34227705-CE6E08AB-FB57-43B5-BEC2-3C5600414F67Q34248598-AC9DB388-B0FC-4419-AD0B-136147EE7D1AQ34302326-0EE261B5-6925-470A-B81D-476EAC1EBA45Q34329428-A47702EB-E710-42A6-8229-02DC96D417D8Q34476458-043E6806-190F-4B0F-8512-37B121414A22Q34479885-BF0AAED1-9E65-44AB-AE5F-BBE3E719782AQ34508212-6852CEC6-4C02-457D-92BD-8EB229B9A084Q34588218-E5C473B0-DF8B-4927-A477-DDB5F5802670Q34596390-EB2DF612-1000-4638-9AF2-CB0BF26B71D3Q34667899-41E20F79-BEF3-4E08-9FE4-2E87510885E1Q34734453-141D95C4-B9F9-4204-A6D2-8F0E4E34AB93Q35067509-F29D7894-A44B-4736-9454-8D701EDC40E9Q35823858-9A6CD6D1-7331-40B6-A64C-73C12BE40D1CQ35869652-274B6C68-911F-4627-A1EF-7CB46C4D0574Q36060763-6C34738C-561E-47AB-8BD8-7B110C210603Q36077471-714495F8-F34F-4767-832C-EC36F915DFEFQ36091066-E083D622-3D47-4D3D-BB01-3448D51FB45BQ36135690-65057D2D-05E6-4B8B-AA7C-51FA31C71022Q36760575-2D304011-EEFF-474C-A829-92CE745A05BFQ37374653-90BDA965-4534-4EE7-99CE-55A6C767A376Q37852307-6882AD33-4A7F-4EF6-B4F0-1AAAADCA5CADQ37974701-654637F5-9830-46CE-B420-F7B039A852B3Q38035109-A0DC08C5-F1F2-4B90-BA45-080831DA4E90Q38181903-24F4238A-1DEE-4475-B6FD-0298F299C59DQ38286552-2A664E6A-FEC9-4529-8A5A-19F055762DC2Q38613637-403A719D-312F-498A-9749-1CE93E899B7DQ38664093-832143F7-B0E1-430B-AE01-67A022E8E7B0Q38838619-EB8B72F2-9D52-4563-8B9D-0BA3BB4DCF27Q38858861-AB7B2994-715B-40DF-AE91-D526745A751EQ38882683-AD659322-A4EB-4B0E-A745-13E2E6FF24BAQ38912262-5A42D126-FFC5-43F9-80E0-77FFB426363FQ38912269-1F6009C7-2563-4217-9512-29E28496E695Q38919105-56C54FA0-74D7-469B-BF07-21C07F1244DB
P50
name
Beverly Winikoff
@en
Beverly Winikoff
@nl
type
label
Beverly Winikoff
@en
Beverly Winikoff
@nl
prefLabel
Beverly Winikoff
@en
Beverly Winikoff
@nl